Oppenheimer HoldingsNYSE: OPY

Bhatia's Addition Exemplifies Continued Deployment of Resources  Towards Building a Leading Life Sciences Practice NEW YORK , June 24, 2024 /PRNewswire/ -- Oppenheimer & Co. Inc. (Oppenheimer) — a leading investment bank, wealth manager and a subsidiary of Oppenheimer Holdings (NYSE: OPY) — announced today that Kunal Bhatia joined as a Managing Director in the firm's Healthcare Investment Banking Group. He will be based in New York and report to Michael Margolis, R.Ph, Oppenheimer's Co-Head of Healthcare and Head of Healthcare Life Sciences Investment Banking.

Brian Nagel, Oppenheimer senior equity research analyst, joins 'Squawk on the Street' to discuss his thoughts on Nike, where most of his concerns come from with Nike, and much more.

TEL AVIV, Israel, June 20, 2024 (GLOBE NEWSWIRE) -- via IBN –- HUB Cyber Security Ltd. (NASDAQ: HUBC), a developer of confidential computing cybersecurity solutions and advanced data services, today released the following statement regarding recent press reports about a settlement with Oppenheimer & Co.:

MOORESVILLE, N.C. , June 19, 2024 /PRNewswire/ -- Lowe's Companies, Inc. (NYSE: LOW) announces that Marvin R.

REDWOOD CITY, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address mast cell driven diseases such as chronic spontaneous urticaria (CSU), chronic inducible urticaria (CIndU) and asthma, today announced today announced that its management will present at the Oppenheimer Novel Targets in Immunology Summit, to be held on Monday, June 24, 2024, in New York City.

WAYNE, Pa. and ROCKVILLE, Md., June 17, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) announced today that Garry A. Neil, M.D., Chief Executive Officer and Chairman of the Board, will present on the Novel Immunological Mechanisms for Dermatological Disorders Panel being held at 11:45 AM ET on June 24, 2024 at the Oppenheimer Novel Targets in Immunology Summit in New York, NY.

Oppenheimer has raised Nvidia's (NVDA) price target to $150 from $110 following its 10-for-1 stock split. Yahoo Finance's Alexandra Canal and Brad Smith report more on the call and the tailwinds ahead for the chip giant.

PHILADELPHIA, PA, June 06, 2024 (GLOBE NEWSWIRE) -- Five Below, Inc. (NASDAQ: FIVE), the trend-right, high-quality extreme-value retailer for tweens, teens and beyond, today announced that management will participate in Oppenheimer's 24th Annual Consumer Growth and E-Commerce Conference to be held virtually. Management is currently scheduled to participate in a fireside chat on Wednesday, June 12, 2024 at 2:15 p.m. Eastern Time.

MINNEAPOLIS--(BUSINESS WIRE)--Best Buy (NYSE: BBY) announces that Corie Barry, chief executive officer, and Matt Bilunas, chief financial officer, are scheduled to participate in a virtual fireside chat at the Oppenheimer Annual Consumer Growth and E-Commerce Conference on June 10, 2024, at 11:15 a.m. Eastern Time. A webcast of the event will be available at www.investors.bestbuy.com both live and after the event.